CA125 Cancer Antigen

<strong>CA125 Cancer Antigen</strong>_x000D_ <strong>Catalog number:</strong> B2013969_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 kU_x000D_ <strong>Molecular Weight or Concentration:</strong> 200 - 1000 kDa_x000D_ <strong>Supplied as:</strong> N/A_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> CA125 Cancer Antigen_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188503._x000D_ 2: Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review J Ovarian Res. 2019 Mar 27;12(1):28._x000D_ 3: Bonifcio VDB. Ovarian Cancer Biomarkers: Moving Forward in Early Detection Adv Exp Med Biol. 2020;1219:355-363._x000D_ 4: Bouanene H, Miled A. Conflicting views on the molecular structure of the cancer antigen CA125/MUC16 Dis Markers. 2010;28(6):385-94._x000D_ 5: Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK. MUC16 as a novel target for cancer therapy Expert Opin Ther Targets. 2018 Aug;22(8):675-686._x000D_ 6: Paijens ST, Leffers N, Daemen T, Helfrich W, Boezen HM, Cohlen BJ, Melief CJ, de Bruyn M, Nijman HW. Antigen-specific active immunotherapy for ovarian cancer Cochrane Database Syst Rev. 2018 Sep 10;9(9):CD007287._x000D_ 7: Whitehouse C, Solomon E. Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening Gynecol Oncol. 2003 Jan;88(1 Pt 2):S152-7._x000D_ 8: Liu C, Deng S, Jin K, Gong Y, Cheng H, Fan Z, Qian Y, Huang Q, Ni Q, Luo G, Yu X. Lewis antigennegative pancreatic cancer: An aggressive subgroup Int J Oncol. 2020 Apr;56(4):900-908._x000D_ 9: Jankovic MM, Milutinovic BS. Glycoforms of CA125 antigen as a possible cancer marker Cancer Biomark. 2008;4(1):35-42._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/25551948">10: Farghaly SA. Current diagnosis and management of ovarian cysts Clin Exp Obstet Gynecol. 2014;41(6):609-12.</a>_x000D_ _x000D_ <strong>Products Related to CA125 Cancer Antigen can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>